Substance Abuse and Mental Health Services Administration September 2022 – Federal Register Recent Federal Regulation Documents

Fiscal Year (FY) 2022 Notice of Supplemental Funding Opportunity
Document Number: 2022-20436
Type: Notice
Date: 2022-09-21
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
This notice is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) is supporting an administrative supplement (in scope of the parent award) up to $20,833 (total costs) for one-year to the Improving Access to Overdose Treatment grant recipients for a total of up to $104,165 (total funding). These recipients were funded in FY 2018 with a project end date of September 30, 2023. The supplemental funding will be utilized specifically to increase the number of health care providers and pharmacists who receive training and technical assistance on the prescribing of drugs or devices approved or cleared under the FDA for emergency treatment of known or suspected opioid overdose.
Fiscal Year (FY) 2022 Notice of Supplemental Funding Opportunity
Document Number: 2022-20321
Type: Notice
Date: 2022-09-20
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
This notice is a notice of intent to award supplemental funding to the nine Minority Fellowship recipients funded in FY 2018 under Notice of Funding Opportunity (NOFO) SM-18-002 and TI-18-013 and in FY 2020 under NOFO SM-20-013. This is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) is supporting one-year administrative supplements, which are consistent with the initial award, up to $209,996 each for eight Minority Fellowship Program (MFP) recipients funded under NOFO SM-18-002 and SM- 20-013, and up to $119,053 for the MFP recipient funded under NOFO TI- 18-013, for a total of $1,799,019.
Fiscal Year (FY) 2022 Notice of Supplemental Funding Opportunity
Document Number: 2022-18976
Type: Notice
Date: 2022-09-02
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
This is a notice of intent to award supplemental funding to the National Center of Excellence for Infant and Early Childhood Mental Health Consultation (COE-IECMH) recipient funded in FY 2019 under Notice of Funding Opportunity (NOFO) SM-19-010. This is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) is supporting an administrative supplement, which is consistent of the initial award, up to $900,000 (for one-year to Georgetown University). This supplement will provide continued support for the IECMH grantees in their efforts to strengthen their IECMH systems; working with state-level systems and leaders to integrate grantee innovations into ongoing initiatives, policies, and sustainable funding streams, and/or participate in the development of new IECMH efforts; share best practices and advances in infant and early childhood mental health with the early childhood field through webinars, presentations at conferences, and/or development of materials about specific grant programs that can be shared with local, Tribal, and state stakeholders; and conduct a virtual grantee meeting or policy academy to engage all grantees in peer learning and technical assistance. This is not a formal request for application. Assistance will only be provided to the COE-IECMH. This recipient was funded in FY 2019 under National Center of Excellence for Infant and Early Childhood Mental Health Consultation Grant, NOFO SM-19-010 with a project end date of April 30, 2023. This is not a formal request for application. Assistance will only be provided to the COE-IECMH grant recipient, Georgetown University, based on the receipt of a satisfactory application and associated budget that is approved by a review group.
Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies
Document Number: 2022-18876
Type: Notice
Date: 2022-09-01
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITFs) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine or Oral Fluid (Mandatory Guidelines).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.